Use of acid-suppression therapy for treatment of non-variceal upper gastrointestinal bleeding

Keith M. Olsen

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Purpose. Prognostic factors in patients with peptic ulcer bleeding and therapeutic strategies for preventing the recurrence of bleeding are described. Summary. The risk of complications and death in a patient with acute upper gastrointestinal bleeding can be predicted based on certain clinical factors, the most important being the endoscopic findings. Proton pump inhibitors (PPIs) are the drugs of choice for patients with peptic ulcer bleeding because the drugs are more effective than histamine H2-receptor antagonists for maintaining the target intragastric pH (6 or higher) and preventing the recurrence of peptic ulcer bleeding, although an impact on mortality has not been demonstrated. High-dose intravenous PPI therapy should be used for patients at high risk of rebleeding (based on endoscopic findings). Oral PPI therapy may be used for low-risk patients. Underlying causes of ulcers should also be addressed and treated as necessary. Conclusion. Acid-suppression therapy using PPIs is effective for reducing the risk for recurrence of peptic ulcer bleeding.

Original languageEnglish (US)
Pages (from-to)S18-S23
JournalAmerican Journal of Health-System Pharmacy
Volume62
Issue numberSUPPL. 2
StatePublished - May 15 2005

Fingerprint

Proton Pump Inhibitors
Hemorrhage
Peptic Ulcer
Acids
Recurrence
Therapeutics
Histamine H2 Antagonists
Pharmaceutical Preparations
Ulcer
Mortality

Keywords

  • Dosage
  • Drug administration routes
  • Gastrointestinal drugs
  • Gastrointestinal hemorrhage
  • Mortality
  • Ulcers

ASJC Scopus subject areas

  • Pharmacology
  • Health Policy

Cite this

Use of acid-suppression therapy for treatment of non-variceal upper gastrointestinal bleeding. / Olsen, Keith M.

In: American Journal of Health-System Pharmacy, Vol. 62, No. SUPPL. 2, 15.05.2005, p. S18-S23.

Research output: Contribution to journalArticle

@article{1b240f03b456425a9952e0b4f6990081,
title = "Use of acid-suppression therapy for treatment of non-variceal upper gastrointestinal bleeding",
abstract = "Purpose. Prognostic factors in patients with peptic ulcer bleeding and therapeutic strategies for preventing the recurrence of bleeding are described. Summary. The risk of complications and death in a patient with acute upper gastrointestinal bleeding can be predicted based on certain clinical factors, the most important being the endoscopic findings. Proton pump inhibitors (PPIs) are the drugs of choice for patients with peptic ulcer bleeding because the drugs are more effective than histamine H2-receptor antagonists for maintaining the target intragastric pH (6 or higher) and preventing the recurrence of peptic ulcer bleeding, although an impact on mortality has not been demonstrated. High-dose intravenous PPI therapy should be used for patients at high risk of rebleeding (based on endoscopic findings). Oral PPI therapy may be used for low-risk patients. Underlying causes of ulcers should also be addressed and treated as necessary. Conclusion. Acid-suppression therapy using PPIs is effective for reducing the risk for recurrence of peptic ulcer bleeding.",
keywords = "Dosage, Drug administration routes, Gastrointestinal drugs, Gastrointestinal hemorrhage, Mortality, Ulcers",
author = "Olsen, {Keith M.}",
year = "2005",
month = "5",
day = "15",
language = "English (US)",
volume = "62",
pages = "S18--S23",
journal = "American Journal of Health-System Pharmacy",
issn = "1079-2082",
publisher = "American Society of Health-Systems Pharmacy",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Use of acid-suppression therapy for treatment of non-variceal upper gastrointestinal bleeding

AU - Olsen, Keith M.

PY - 2005/5/15

Y1 - 2005/5/15

N2 - Purpose. Prognostic factors in patients with peptic ulcer bleeding and therapeutic strategies for preventing the recurrence of bleeding are described. Summary. The risk of complications and death in a patient with acute upper gastrointestinal bleeding can be predicted based on certain clinical factors, the most important being the endoscopic findings. Proton pump inhibitors (PPIs) are the drugs of choice for patients with peptic ulcer bleeding because the drugs are more effective than histamine H2-receptor antagonists for maintaining the target intragastric pH (6 or higher) and preventing the recurrence of peptic ulcer bleeding, although an impact on mortality has not been demonstrated. High-dose intravenous PPI therapy should be used for patients at high risk of rebleeding (based on endoscopic findings). Oral PPI therapy may be used for low-risk patients. Underlying causes of ulcers should also be addressed and treated as necessary. Conclusion. Acid-suppression therapy using PPIs is effective for reducing the risk for recurrence of peptic ulcer bleeding.

AB - Purpose. Prognostic factors in patients with peptic ulcer bleeding and therapeutic strategies for preventing the recurrence of bleeding are described. Summary. The risk of complications and death in a patient with acute upper gastrointestinal bleeding can be predicted based on certain clinical factors, the most important being the endoscopic findings. Proton pump inhibitors (PPIs) are the drugs of choice for patients with peptic ulcer bleeding because the drugs are more effective than histamine H2-receptor antagonists for maintaining the target intragastric pH (6 or higher) and preventing the recurrence of peptic ulcer bleeding, although an impact on mortality has not been demonstrated. High-dose intravenous PPI therapy should be used for patients at high risk of rebleeding (based on endoscopic findings). Oral PPI therapy may be used for low-risk patients. Underlying causes of ulcers should also be addressed and treated as necessary. Conclusion. Acid-suppression therapy using PPIs is effective for reducing the risk for recurrence of peptic ulcer bleeding.

KW - Dosage

KW - Drug administration routes

KW - Gastrointestinal drugs

KW - Gastrointestinal hemorrhage

KW - Mortality

KW - Ulcers

UR - http://www.scopus.com/inward/record.url?scp=18644370033&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18644370033&partnerID=8YFLogxK

M3 - Article

C2 - 15905596

AN - SCOPUS:18644370033

VL - 62

SP - S18-S23

JO - American Journal of Health-System Pharmacy

JF - American Journal of Health-System Pharmacy

SN - 1079-2082

IS - SUPPL. 2

ER -